Emkay Global Financial's report on HDFC Life
HDFC Life (HDFCSL) reported VNB margins of 26.2% (+180bps yoy) in Q1FY22. The share of individual protection products declined ~4% yoy as the share of ULIPs rose in overall AUM. The company witnessed disruption in business activities in May’21; however, other products like annuity and credit life performed well. HDFCSL saw a steep rise in death claims, with peak claims in the second Covid wave at ~3-4 times of peak claims in the first wave. The company cleared ~70,000 claims in Q1, with gross/net claims amounting to Rs16bn/Rs9.6bn. The company has created an additional reserve of ~Rs7bn; however, near-term uncertainties persist.
Outlook
We roll forward our TP to Sep’22E and maintain Buy (OW in EAP) with a revised TP of Rs870 (Rs848 previously), corresponding to 4.5x P/Sep’23E EV.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.